 |
|||||
|
|||||
|
|||||
|
|||||
|
|||||
Previous Article | Next Article
The Journal of Neuroscience, March 1, 2001, 21(5):1481-1489
Insulin-Like Growth Factor-I Overexpression Attenuates Cerebellar Apoptosis by Altering the Expression of Bcl Family Proteins in a Developmentally Specific Manner
Dionisios Chrysis, Ali Suha Calikoglu, Ping Ye, and A. Joseph D'Ercole Department of Pediatrics, The University of North Carolina, Chapel Hill, North Carolina 27599-7220
In studies of transgenic (Tg) mice that overexpress insulin-like growth factor-I (IGF-I) exclusively in the CNS, we demonstrated a dramatic increase in cerebellar granule cell number that appeared to be attributable predominantly to enhanced survival. IGF-I anti-apoptotic actions are well established in cultured neurons, but comparable studies in vivo are few. Using the same Tg mice, therefore, we set out to document IGF-I anti-apoptotic effects during cerebellar development and to probe IGF-I signaling mechanisms. Compared with cerebella (CBs) of non-Tg littermates, those of Tg mice had fewer apoptotic cells at postnatal day 7 (P7) and showed a similar tendency at P14 and P21. At each age studied, procaspase-3 and caspase-3 were decreased in CBs of Tg mice. The caspase-3 decline was accompanied by decreases in the 85 kDa fragment of Poly(ADP-ribose) polymerase, a known product of caspase cleavage, suggesting decreased caspase activity. At P7 decreased apoptosis in Tg mice was associated with increased expression of the anti-apoptotic Bcl genes, Bcl-xL and Bcl-2. The mRNA expression of the proapoptotic Bcl genes, Bax and Bad, also was increased, but no changes were observed in the abundance of their proteins. At P14 Bcl-xL and Bcl-2 expression were similar in normal and Tg mice; Bax mRNA was unchanged in Tg mice, but its protein abundance was decreased, and both Bad mRNA and protein abundance were decreased. At P21 Bcl-xL and Bcl-2 expression were unchanged, but Bax and Bad expression were decreased. Our data show that IGF-I exerts anti-apoptotic actions during cerebellar development, and thereby alters the magnitude of naturally occurring apoptosis. IGF-I appears to affect multiple steps in the apoptotic pathway in a developmentally specific manner. IGF-I decreases caspase-3 availability and activity, increases the expression of anti-apoptotic Bcl-xL and Bcl-2 during early postnatal development, and decreases proapoptotic Bax and Bad expression at later developmental stages.
Key words: IGF-I; apoptosis; cerebellum; development; transgenic mice; Bcl; Bcl-2; Bcl-xL; Bad; Bax; caspase-3; Poly(ADP-ribose) polymerase
Copyright © 2001 Society for Neuroscience 0270-6474/01/2151481-09$05.00/0
This article has been cited by other articles:
A. Joseph D'Ercole and P. Ye
Expanding the Mind: Insulin-Like Growth Factor I and Brain Development
Endocrinology, December 1, 2008; 149(12): 5958 - 5962.
[Abstract] [Full Text] [PDF]
P. Onori, D. Alvaro, A. Floreani, M. Mancino, A. Franchitto, M. Guido, G. Carpino, A. De Santis, M. Angelico, A. F. Attili, et al.
Activation of the IGF1 System Characterizes Cholangiocyte Survival During Progression of Primary Biliary Cirrhosis
J. Histochem. Cytochem., April 1, 2007; 55(4): 327 - 334.
[Abstract] [Full Text] [PDF]
L. Y. Sun and A. J. D'Ercole
Insulin-Like Growth Factor-I Stimulates Histone H3 and H4 Acetylation in the Brain in Vivo
Endocrinology, November 1, 2006; 147(11): 5480 - 5490.
[Abstract] [Full Text] [PDF]
D. Chrysis, F. Zaman, A. S. Chagin, M. Takigawa, and L. Savendahl
Dexamethasone Induces Apoptosis in Proliferative Chondrocytes through Activation of Caspases and Suppression of the Akt-Phosphatidylinositol 3'-Kinase Signaling Pathway
Endocrinology, March 1, 2005; 146(3): 1391 - 1397.
[Abstract] [Full Text] [PDF]
R. D. Hodge, A. J. D'Ercole, and J. R. O'Kusky
Insulin-Like Growth Factor-I Accelerates the Cell Cycle by Decreasing G1 Phase Length and Increases Cell Cycle Reentry in the Embryonic Cerebral Cortex
J. Neurosci., November 10, 2004; 24(45): 10201 - 10210.
[Abstract] [Full Text] [PDF]
G. Bienvenu, D. Seurin, P. Grellier, P. Froment, M. Baudrimont, P. Monget, Y. Le Bouc, and S. Babajko
Insulin-Like Growth Factor Binding Protein-6 Transgenic Mice: Postnatal Growth, Brain Development, and Reproduction Abnormalities
Endocrinology, May 1, 2004; 145(5): 2412 - 2420.
[Abstract] [Full Text] [PDF]
H. Shan, M. L. Messi, Z. Zheng, Z.-M. Wang, and O. Delbono
Preservation of motor neuron Ca2+ channel sensitivity to insulin-like growth factor-1 in brain motor cortex from senescent rat
J. Physiol., November 15, 2003; 553(1): 49 - 63.
[Abstract] [Full Text] [PDF]
C.-D. Oh and J.-S. Chun
Signaling Mechanisms Leading to the Regulation of Differentiation and Apoptosis of Articular Chondrocytes by Insulin-like Growth Factor-1
J. Biol. Chem., September 19, 2003; 278(38): 36563 - 36571.
[Abstract] [Full Text] [PDF]
D. Vaudry, A. Falluel-Morel, S. Leuillet, H. Vaudry, and B. J. Gonzalez
Regulators of Cerebellar Granule Cell Development Act Through Specific Signaling Pathways
Science, June 6, 2003; 300(5625): 1532 - 1534.
[Abstract] [Full Text] [PDF]
J. Gonzalez, A. Orlofsky, and M. B. Prystowsky
A1 is a growth-permissive antiapoptotic factor mediating postactivation survival in T cells
Blood, April 1, 2003; 101(7): 2679 - 2685.
[Abstract] [Full Text] [PDF]
L. M. Frago, S. Canon, E. J. de la Rosa, Y. Leon, and I. Varela-Nieto
Programmed cell death in the developing inner ear is balanced by nerve growth factor and insulin-like growth factor I
J. Cell Sci., February 1, 2003; 116(3): 475 - 486.
[Abstract] [Full Text] [PDF]
S. Alas and B. Bonavida
Inhibition of Constitutive STAT3 Activity Sensitizes Resistant Non-Hodgkin's Lymphoma and Multiple Myeloma to Chemotherapeutic Drug-mediated Apoptosis
Clin. Cancer Res., January 1, 2003; 9(1): 316 - 326.
[Abstract] [Full Text] [PDF]
D. A. Linseman, R. A. Phelps, R. J. Bouchard, S. S. Le, T. A. Laessig, M. L. McClure, and K. A. Heidenreich
Insulin-Like Growth Factor-I Blocks Bcl-2 Interacting Mediator of Cell Death (Bim) Induction and Intrinsic Death Signaling in Cerebellar Granule Neurons
J. Neurosci., November 1, 2002; 22(21): 9287 - 9297.
[Abstract] [Full Text] [PDF]
L. M. Frago, C. Paneda, S. L. Dickson, A. K. Hewson, J. Argente, and J. A. Chowen
Growth Hormone (GH) and GH-Releasing Peptide-6 Increase Brain Insulin-Like Growth Factor-I Expression and Activate Intracellular Signaling Pathways Involved in Neuroprotection
Endocrinology, October 1, 2002; 143(10): 4113 - 4122.
[Abstract] [Full Text] [PDF]
H. R. Wilkins, K. Ohneda, T. O. Keku, A. J. D'Ercole, C. R. Fuller, K. L. Williams, and P. K. Lund
Reduction of spontaneous and irradiation-induced apoptosis in small intestine of IGF-I transgenic mice
Am J Physiol Gastrointest Liver Physiol, August 1, 2002; 283(2): G457 - G464.
[Abstract] [Full Text] [PDF]
R. Rajah, K.-W. Lee, and P. Cohen
Insulin-like Growth Factor Binding Protein-3 Mediates Tumor Necrosis Factor-{alpha}-induced Apoptosis: Role of Bcl-2 Phosphorylation
Cell Growth Differ., April 1, 2002; 13(4): 163 - 171.
[Abstract] [Full Text] [PDF]
|
|
|
|
 |
|